Casdin Capital’s Eli Casdin and Corvex Management’s Keith Meister are teaming up again to launch a new blank-check company.
They are planning the offering even though their first SPAC hasn’t yet found a merger partner.
CM Life Sciences II said in a regulatory filing it is seeking to raise at least $200 million.
